Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sharma JN - Reduced activity of the bradykinin system has been observed in various hypertensive situations in both clinical and experimental models of hypertension. Antihypertensive properties of the angiotensin-converting enzyme or kininase II inhibitors are primarily mediated via the bradykinin-releasing pathway, which may also cause regression of left ventricular hypertrophy in hypertensive situations. The ability of kallikrein gene delivery to produce a wide spectrum of beneficial effects makes it an excellent candidate for treating hypertension and cardiovascular and renal diseases. In addition, stable bradykinin agonists may also be available in the future as therapeutic agents for cardio vascular and renal disorders.

Today in Hypertension...keeping you current

Association of Calcium-Phosphorus Product With Blood Pressure in Dialysis
The Journal of Clinical Hypertension, 12/15/09

Stress imaging in congenital cardiac disease
Cardiology in the Young, 12/14/09

Myocardial remodeling in low-renin hypertension: Molecular pathways to cellular injury in relative aldosteronism
Current Hypertension Reports, 12/14/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address